• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国武汉 HIV 感染者的 COVID-19 疫苗接种意愿。

COVID-19 Vaccination Willingness Among People Living With HIV in Wuhan, China.

机构信息

Department of Nosocomial Infection Management, Zhongnan Hospital of Wuhan University, Wuhan, China.

Hubei Engineering Center for Infectious Disease Prevention, Control and Treatment, Wuhan, China.

出版信息

Front Public Health. 2022 May 9;10:883453. doi: 10.3389/fpubh.2022.883453. eCollection 2022.

DOI:10.3389/fpubh.2022.883453
PMID:35615040
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9124942/
Abstract

Vaccination is essential to controlling the pandemic of coronavirus disease 2019 (COVID-19). People living with HIV (PLWH) were considered more vulnerable to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection compared with the general population. Therefore, it is urgent to protect PLWH from SARS-CoV-2 infection. For PLWH, vaccine hesitancy could be more common and may compromise vaccine coverage. Our study aimed to investigate the willingness to receive the COVID-19 vaccination among PLWH and associated factors. A cross-sectional online survey was performed among PLWH and the general population from 4 April to 18 April 2021 in Wuhan, China. The multivariable logistic regression was used to analyze associated factors for COVID-19 vaccination willingness among PLWH. A total of 556 PLWH and 570 individuals from the general population were enrolled. The COVID-19 vaccine willingness among PLWH was 60.8%, which was relatively lower than that in the general population (80.9%) ( < 0.001). The results of multivariable analysis indicated that PLWH with comorbidities (OR = 2.07, 95% CI: 1.25-3.45), those who had idea about PLWH would be more serious if they were infected with SARS-CoV-2 (OR = 1.67, 95% CI: 1.11-2.51) and those who thought their antiretroviral therapy (ART) would be affected by COVID-19 epidemic (OR = 2.04, 95% CI: 1.22-3.42) had higher willingness to receive COVID-19 vaccination. PLWH who had a monthly income over 5,000 RMB (OR = 0.64, 95% CI: 0.45-0.92) and had a sex orientation as non-homosexual (OR = 0.67, 95% CI: 0.47-0.96) were associated with lower willingness for COVID-19 vaccination. Our findings showed that the PLWH had a lower willingness for COVID-19 vaccination compared with the general population in Wuhan. Targeted interventions such as health education should be conducted to increase the willingness for COVID-19 vaccination among PLWH, thus enhancing COVID-19 vaccine uptake among PLWH.

摘要

接种疫苗对于控制 2019 年冠状病毒病(COVID-19)大流行至关重要。与一般人群相比,艾滋病毒感染者(PLWH)被认为更容易受到严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染。因此,迫切需要保护 PLWH 免受 SARS-CoV-2 感染。对于 PLWH,疫苗犹豫可能更为普遍,并可能影响疫苗接种率。我们的研究旨在调查 PLWH 对 COVID-19 疫苗接种的意愿及其相关因素。我们于 2021 年 4 月 4 日至 4 月 18 日期间在中国武汉对 PLWH 和一般人群进行了横断面在线调查。多变量逻辑回归用于分析 PLWH 对 COVID-19 疫苗接种意愿的相关因素。共纳入 556 名 PLWH 和 570 名一般人群。PLWH 对 COVID-19 疫苗的接种意愿为 60.8%,相对低于一般人群(80.9%)(<0.001)。多变量分析结果表明,患有合并症的 PLWH(OR=2.07,95%CI:1.25-3.45)、认为 PLWH 如果感染 SARS-CoV-2 会更严重的人(OR=1.67,95%CI:1.11-2.51)和认为他们的抗逆转录病毒治疗(ART)会受到 COVID-19 流行影响的人(OR=2.04,95%CI:1.22-3.42)对 COVID-19 疫苗接种的意愿更高。月收入超过 5000 元人民币(OR=0.64,95%CI:0.45-0.92)和性取向为非同性恋(OR=0.67,95%CI:0.47-0.96)的 PLWH 与对 COVID-19 疫苗接种的意愿较低有关。我们的研究结果表明,与武汉一般人群相比,PLWH 对 COVID-19 疫苗接种的意愿较低。应开展有针对性的干预措施,如健康教育,以提高 PLWH 对 COVID-19 疫苗接种的意愿,从而提高 PLWH 对 COVID-19 疫苗的接种率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b812/9124942/7070e280657a/fpubh-10-883453-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b812/9124942/9b6dece11cb9/fpubh-10-883453-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b812/9124942/7070e280657a/fpubh-10-883453-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b812/9124942/9b6dece11cb9/fpubh-10-883453-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b812/9124942/7070e280657a/fpubh-10-883453-g0002.jpg

相似文献

1
COVID-19 Vaccination Willingness Among People Living With HIV in Wuhan, China.中国武汉 HIV 感染者的 COVID-19 疫苗接种意愿。
Front Public Health. 2022 May 9;10:883453. doi: 10.3389/fpubh.2022.883453. eCollection 2022.
2
Willingness of people living with HIV to receive a second COVID-19 booster dose: a multicenter cross-sectional study in China.中国一项多中心横断面研究:艾滋病毒感染者接受第二剂 COVID-19 加强针的意愿。
Front Public Health. 2023 Aug 23;11:1227277. doi: 10.3389/fpubh.2023.1227277. eCollection 2023.
3
Willingness to receive the COVID-19 vaccine among HIV positive men who have sex with men in China: a cross-sectional study.中国 HIV 阳性男男性行为者对 COVID-19 疫苗的接种意愿:一项横断面研究。
BMC Public Health. 2023 Jan 10;23(1):64. doi: 10.1186/s12889-022-14961-5.
4
Acceptance of COVID-19 vaccination and influencing factors among people living with HIV in Guangxi, China: a cross-sectional survey.中国广西地区 HIV 感染者对 COVID-19 疫苗的接种意愿及影响因素:一项横断面调查。
BMC Infect Dis. 2022 May 16;22(1):471. doi: 10.1186/s12879-022-07452-w.
5
COVID-19 vaccine uptake and hesitancy among HIV-infected men who have sex with men in mainland China: a cross-sectional survey.中国大陆 HIV 感染的男男性行为者中 COVID-19 疫苗接种率和犹豫情况:一项横断面调查。
Hum Vaccin Immunother. 2021 Dec 2;17(12):4971-4981. doi: 10.1080/21645515.2021.1996152. Epub 2021 Dec 10.
6
Are people living with HIV have a low vulnerability to omicron variant infection: results from a cross-sectional study in China.HIV 感染者对奥密克戎变异株感染的脆弱性较低:来自中国的横断面研究结果。
BMC Infect Dis. 2023 Nov 14;23(1):795. doi: 10.1186/s12879-023-08768-x.
7
COVID-19 vaccination willingness among people living with HIV in Shijiazhuang, China: a cross-sectional survey.中国石家庄HIV感染者的新冠病毒疫苗接种意愿:一项横断面调查
Front Med (Lausanne). 2024 Jan 17;11:1322440. doi: 10.3389/fmed.2024.1322440. eCollection 2024.
8
Willingness to Receive COVID-19 Vaccination Among People Living With HIV and AIDS in China: Nationwide Cross-sectional Online Survey.中国 HIV 感染者和 AIDS 患者对 COVID-19 疫苗接种的意愿:全国横断面在线调查。
JMIR Public Health Surveill. 2021 Oct 21;7(10):e31125. doi: 10.2196/31125.
9
Risk of SARS-CoV-2 Infection Among People Living With HIV in Wuhan, China.中国武汉 HIV 感染者感染 SARS-CoV-2 的风险。
Front Public Health. 2022 Apr 29;10:833783. doi: 10.3389/fpubh.2022.833783. eCollection 2022.
10
People living with HIV with the Omicron variant infection have milder COVID-19 symptoms: results from a cross-sectional study.奥密克戎变异株感染的 HIV 感染者的 COVID-19 症状较轻:一项横断面研究的结果。
AIDS Res Ther. 2024 Aug 10;21(1):53. doi: 10.1186/s12981-024-00633-4.

引用本文的文献

1
Tolerance of Inactivated SARS-CoV-2 Vaccine for People Living with HIV: A Real-World Evidence Analysis from a Retrospective Cohort Study.HIV感染者对新型冠状病毒灭活疫苗的耐受性:一项回顾性队列研究的真实世界证据分析
J Epidemiol Glob Health. 2025 Aug 14;15(1):106. doi: 10.1007/s44197-025-00452-4.
2
Online course on vaccinating people with HIV/AIDS - effectiveness in the knowledge of nursing professionals.在线艾滋病毒/艾滋病疫苗接种课程 - 对护理专业人员知识的影响。
Rev Lat Am Enfermagem. 2024 Aug 12;32:e4278. doi: 10.1590/1518-8345.7004.4278. eCollection 2024.
3
Accelerating COVID-19 Vaccination Among People Living With HIV and Health Care Workers in Tanzania: A Case Study.

本文引用的文献

1
Management of and Revitalization Strategy for Megacities Under Major Public Health Emergencies: A Case Study of Wuhan.重大公共卫生事件下特大城市的治理与复兴策略:以武汉市为例
Front Public Health. 2022 Jan 27;9:797775. doi: 10.3389/fpubh.2021.797775. eCollection 2021.
2
Immunogenicity and safety of the BNT162b2 COVID-19 mRNA vaccine in PLWH: A monocentric study in Bari, Italy.在感染 HIV 的人群中,BNT162b2 COVID-19 mRNA 疫苗的免疫原性和安全性:来自意大利巴里的一项单中心研究。
J Med Virol. 2022 May;94(5):2230-2236. doi: 10.1002/jmv.27629. Epub 2022 Feb 8.
3
Effect of an IMB Model-Based Education on the Acceptability of HPV Vaccination Among College Girls in Mainland China: A Cluster RCT.
在坦桑尼亚加快艾滋病毒感染者和卫生保健工作者中的 COVID-19 疫苗接种:案例研究。
Glob Health Sci Pract. 2024 Jun 27;12(3). doi: 10.9745/GHSP-D-23-00281.
4
COVID-19 Vaccine Hesitancy Among People Living with HIV: A Systematic Review and Meta-Analysis.COVID-19 疫苗犹豫在 HIV 感染者中的研究:系统综述和荟萃分析。
AIDS Behav. 2024 Jul;28(7):2183-2192. doi: 10.1007/s10461-024-04344-9. Epub 2024 Apr 16.
5
COVID-19 vaccination willingness among people living with HIV in Shijiazhuang, China: a cross-sectional survey.中国石家庄HIV感染者的新冠病毒疫苗接种意愿:一项横断面调查
Front Med (Lausanne). 2024 Jan 17;11:1322440. doi: 10.3389/fmed.2024.1322440. eCollection 2024.
6
A systematic review and meta-analysis of the global prevalence and determinants of COVID-19 vaccine acceptance and uptake in people living with HIV.对感染艾滋病毒者中新冠病毒疫苗接受度和接种率的全球流行情况及决定因素的系统评价和荟萃分析。
Nat Hum Behav. 2024 Jan;8(1):100-114. doi: 10.1038/s41562-023-01733-3. Epub 2023 Oct 30.
7
Willingness of people living with HIV to receive a second COVID-19 booster dose: a multicenter cross-sectional study in China.中国一项多中心横断面研究:艾滋病毒感染者接受第二剂 COVID-19 加强针的意愿。
Front Public Health. 2023 Aug 23;11:1227277. doi: 10.3389/fpubh.2023.1227277. eCollection 2023.
8
Assessing SARS-CoV-2 vaccine hesitancy among the people living with and without HIV from May to September 2022 in Blantyre, Malawi.2022 年 5 月至 9 月在马拉维布兰太尔,评估有和没有 HIV 的人群对 SARS-CoV-2 疫苗的犹豫情况。
Hum Vaccin Immunother. 2023 Aug 1;19(2):2222052. doi: 10.1080/21645515.2023.2222052. Epub 2023 Jun 15.
9
The Impact of COVID-19 on People Living with HIV-1 and HIV-1-Associated Neurological Complications.COVID-19 对 HIV-1 感染者和 HIV-1 相关神经并发症的影响。
Viruses. 2023 May 5;15(5):1117. doi: 10.3390/v15051117.
10
The safety and immunogenicity of a two-dose schedule of CoronaVac, and the immune persistence of vaccination for six months, in people living with HIV: A multicenter prospective cohort study.两剂科兴疫苗接种的安全性和免疫原性,以及在 HIV 感染者中接种疫苗六个月后的免疫持久性:一项多中心前瞻性队列研究。
Front Immunol. 2023 Mar 13;14:1129651. doi: 10.3389/fimmu.2023.1129651. eCollection 2023.
基于 IMB 模型的教育对中国内地女大学生 HPV 疫苗接种接受度的影响:一项整群 RCT 研究。
Cancer Control. 2022 Jan-Dec;29:10732748211070719. doi: 10.1177/10732748211070719.
4
Vaccines to prevent COVID-19: A living systematic review with Trial Sequential Analysis and network meta-analysis of randomized clinical trials.预防 COVID-19 的疫苗:一项针对随机临床试验的实时系统评价与序贯分析和网络荟萃分析。
PLoS One. 2022 Jan 21;17(1):e0260733. doi: 10.1371/journal.pone.0260733. eCollection 2022.
5
COVID-19 Vaccination Acceptance in China after It Becomes Available: A Cross-Sectional Study.中国新冠疫苗上市后的接种意愿:一项横断面研究
Vaccines (Basel). 2021 Nov 25;9(12):1398. doi: 10.3390/vaccines9121398.
6
Immunogenicity of an inactivated SARS-CoV-2 vaccine in people living with HIV-1: a non-randomized cohort study.一种灭活严重急性呼吸综合征冠状病毒2(SARS-CoV-2)疫苗在HIV-1感染者中的免疫原性:一项非随机队列研究。
EClinicalMedicine. 2022 Jan;43:101226. doi: 10.1016/j.eclinm.2021.101226. Epub 2021 Dec 4.
7
Adverse events of inactivated COVID-19 vaccine in HIV-infected adults.HIV 感染者中使用灭活 COVID-19 疫苗的不良反应。
AIDS Res Ther. 2021 Dec 4;18(1):92. doi: 10.1186/s12981-021-00416-1.
8
A Prediction Model for High Risk of Positive RT-PCR Test Results in COVID-19 Patients Discharged From Wuhan Leishenshan Hospital, China.中国武汉雷神山医院出院的 COVID-19 患者新冠病毒 RT-PCR 检测结果呈阳性的高风险预测模型。
Front Public Health. 2021 Nov 8;9:778539. doi: 10.3389/fpubh.2021.778539. eCollection 2021.
9
COVID-19 Vaccine Hesitancy Among PLWH in South India: Implications for Vaccination Campaigns.南非印度裔 PLWH 对 COVID-19 疫苗的犹豫:对疫苗接种活动的影响。
J Acquir Immune Defic Syndr. 2021 Dec 15;88(5):421-425. doi: 10.1097/QAI.0000000000002803.
10
Willingness to Get the COVID-19 Vaccine among Residents of Slum Settlements.贫民窟居民接种新冠疫苗的意愿
Vaccines (Basel). 2021 Aug 26;9(9):951. doi: 10.3390/vaccines9090951.